Company: TBPH
Filing Date: 2025-05-20
Form Type: 8-K
Source: 0001104659-25-051050
Chunk: 0

Company: Theravance Biopharma, Inc.
Filing Date: 2025-05-20
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2025 Annual General Meeting of Shareholders (the “ Annual
Meeting”) of Theravance Biopharma, Inc. (the “ Company”) was held on May 19, 2025. Shareholders holding 45,746,079
shares of capital stock, representing 91.5% of the total number of shares outstanding and entitled to vote at the Annual Meeting, were
present in person or by proxy at the Annual Meeting, which constituted a quorum to conduct business.

The matters voted on at the Annual Meeting are summarized below, and
the votes cast with respect to each such matter are set forth below. These matters are described in more detail in the Company’s
Definitive Proxy Statement filed with the Securities and Exchange Commission on April 10, 2025.

Proposal
One - Based on the following results of voting, the nominees listed below were elected Class II directors to serve
as members of the Board until the Company’s Annual General Meeting held in 2026 and until their successors are duly elected and
qualified:

  Nominees                      For        Against        Abstain                 
 ──────────────────────────────────────────────────────────────────────────────────
  Rick E Winningham      28,586,164      1,965,694      9,513,702      5,680,519  
  Jeremy T. Grant        39,915,281        145,969          4,310      5,680,519  
  Susannah Gray          39,943,074        110,833         11,653      5,680,519  
  Donal O’ Connor        39,871,814        180,335         13,411      5,680,519  

Proposal
Two - Based on the following results of voting, the appointment of Ernst & Young LLP as the Company’s
independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified:

                              For                      Against                   Abstain                 Broker Non-  
                                                                                                         Votes        
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Number of Shares Voted               45,165,816                   578,070                   2,193                   

Proposal
Three - Based on the following results of voting, a non-binding advisory resolution regarding the compensation of the